Type I interferons and dendritic celles in cancer immunotherapy - Sprooten, J., Agostinis P., Garg, A.D - 2019 - Inr Rev Cell Molec Biology - Pubmed

Trial watch: dendritic cell vaccination for cancer immunotherapy - Sprooten, J., Ceusters, J., Coosemans, A., Agostinis, P., De Vlesschouwer, S., Zitvogel, L., Kroemer, G., Galluzzi L., Garg, A.D. - 2019 - Oncoimmunology - Pubmed

Mitophagy in Cancer: A Tale of Adaptation - Vara-Perez, M., Felipe-Abrio, B., Agostinis, P. - 2019 - Cells - Pubmed

Autophagy in endothelial cells and tumor angiogenesis - Schaaf, M.B., Houbaert, D., Mece, O., Agostinis, P. - 2019 - Cell death and differentiation - Pubmed

Lysosomal Pathways and Autophagy Distinctively Control Endothelial Cell Behavior to Affect Tumor Vasculature - Schaaf, M.B., Houbaert, D., Mece, O., To, S.K., Ganne, M., Maes, H., Agostinis, P - 2019 - Frontiers in Oncology - Pubmed

BNIP3 contributes to the glutamine-driven aggressive behavior of melanoma cells - Vara-Perez, M., Maes, H., Van Dingenen, S., Agostinis, P - 2019 - Biological Chemistry - Pubmed

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells - Romano, E., Rufo, N., Korf, H., Mathieu, C., Garg, A.D., Agostinis, P - 2018 - Oncotarget - Pubmed

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy - Schaaf, M., Garg, A., Agostinis, P - 2018 - Cell death & disease - Pubmed

PERK mediates ER-PM contact site formation by interacting with Filamin A and regulating F-actin dynamics - Van Vliet A, Giordano F, Gerlo S, Segura I, Van Eygen S, Molenberghs G, Rocha S, Houcine A, Derua R, Verfaillie T, Vangindertael J, De Keersmacher, Waelkens E, Tavernier J, Hofkens J, Annaert W, Carmeliet P, Samali A, Mizuno H, Agostinis P - 2017 - Molecular Cell - Pubmed

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma - Garg AD, Vandenberk L, Koks C, Verschuere T, Boon L, Van Gool SW, Agostinis P - 2016 - Science Translational Medicine - Pubmed